Bayer Pharma AG

Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. Bayer develops new molecules for use in innovative products and solutions to improve the health of humans in cardiology, women’s health as well as oncology, hematology and ophthalmology.

Key staff involved in EBiSC

Dr. Nils Pfaff (Laboratory Head, Research Scientist) – Dr. Nils Pfaff heads a laboratory focusing on target identification and validation using cell-based assays including human iPSCs. Current focus is on using (patient-derived) iPSCs for in vitro disease modeling. Nils has obtained a M.Sc. in Molecular Medicine from the University of Göttingen, Germany and holds a PhD in Molecular Medicine from Hannover Medical School, Germany.

More information: http://www.bayer.com »